Literature DB >> 11369191

Inherited early onset severe axonal polyneuropathy with respiratory failure and autonomic involvement.

U Mohan1, V P Misra, J Britto, F Muntoni, R H King, P K Thomas.   

Abstract

We report dizygotic twins who first presented at the age of 6 months with severe diaphragmatic weakness and marked abnormalities of autonomic function. A female sibling had earlier died from a disorder with similar clinical features. Both twins had a severe axonal polyneuropathy with generalized hypotonic limb weakness together with diaphragmatic paralysis resulting in respiratory failure. Associated features were tachycardia, increased sweating, elevated body temperature, and hypertension, suggesting autonomic dysfunction. Nerve conduction studies indicated an axonopathy affecting both motor and sensory nerve fibres. Sural nerve biopsy in one twin performed at the age of 7 months showed a reduced population of myelinated nerve fibres, particularly those of larger diameter, with no indication of hypomyelination, demyelination or axonal atrophy. Examples of axonal forms of hereditary motor and sensory neuropathy (HMSN) with onset in infancy are very rare and autonomic involvement associated with this condition has not so far been described.

Entities:  

Mesh:

Year:  2001        PMID: 11369191     DOI: 10.1016/s0960-8966(00)00210-8

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  Distal Spinal Muscular Atrophy: An Overlooked Etiology of Weaning Failure in Children with Respiratory Insufficiency.

Authors:  Mojdeh Habibi Zoham; Asgar Eghbalkhah; Kamyar Kamrani; Nahid Khosroshahi; Hossein Yousefimanesh; Zahra Eskandarizadeh
Journal:  J Pediatr Intensive Care       Date:  2018-01-04

2.  Spinal muscular atrophy with respiratory distress type 1 (SMARD1) Report of a Spanish case with extended clinicopathological follow-up.

Authors:  Beatriz San Millan; Jose M Fernandez; Carmen Navarro; Alfredo Reparaz; Susana Teijeira
Journal:  Clin Neuropathol       Date:  2016 Mar-Apr       Impact factor: 1.368

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.